• FMR, a 10% owner of Avalyn Pharma, sold 228,454 common shares on Nov. 9-10, 2026.
• Nov. 9 sales comprised 173,661 shares at $29.06 each and 1,339 shares at $29.75 each.
• Nov. 10 sales totaled 5,565 shares at $29.56 each and 47,889 shares at $30.28 each.
• Indirect holdings through F-Prime Capital Partners Healthcare Fund V fell to 2,056,081 shares, according to the Form 4 dated Nov. 12.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avalyn Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-457571), on November 12, 2026, and is solely responsible for the information contained therein.